Volume 16, Issue 3 pp. 219-226
Original Article

The development of diabetes among Danish cystic fibrosis patients over the last two decades

Karin B. Knudsen

Corresponding Author

Karin B. Knudsen

Cystic Fibrosis Centre, Rigshospitalet, Copenhagen, 2100 Denmark

Corresponding author: Karin Bæk Knudsen,

Cystic Fibrosis Centre Copenhagen,

Rigshospitalet,

Blegdamsvej 9,

Copenhagen Ø, 2100

Denmark.

Tel: (45) 35453456;

Fax: (45) 35452975;

e-mail: [email protected]

Search for more papers by this author
Elisabeth R. Mathiesen

Elisabeth R. Mathiesen

Department of Endocrinology, Rigshospitalet, Copenhagen, 2100 Denmark

Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

Search for more papers by this author
Vibeke Eriksen

Vibeke Eriksen

Department of Paediatrics, Herlev Hospital, Herlev, 2730 Denmark

Search for more papers by this author
Marianne Skov

Marianne Skov

Paediatric Pulmonary Service, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, 2100 Denmark

Search for more papers by this author
Kim G. Nielsen

Kim G. Nielsen

Paediatric Pulmonary Service, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, 2100 Denmark

Search for more papers by this author
Jesper Johannesen

Jesper Johannesen

Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

Department of Paediatrics, Herlev Hospital, Herlev, 2730 Denmark

Search for more papers by this author
Tacjana Pressler

Tacjana Pressler

Cystic Fibrosis Centre, Rigshospitalet, Copenhagen, 2100 Denmark

Search for more papers by this author
First published: 01 June 2014
Citations: 8

Abstract

Objective

Cystic fibrosis (CF)-related diabetes (CFRD) is correlated with age and has been associated with a decline in body mass index (BMI), pulmonary function, and survival. Over the last two decades, the focus has been on the early diagnosis and treatment of diabetes; therefore, in this study, we evaluated the status of the current clinical condition and survival in our CF population. In addition, we also aimed to investigate the incidence of diabetes among adolescence over time and to identify characteristics associated with early diabetes onset.

Methods

A retrospective chart review of a birth cohort consisting of 161 CF patients born between 1975 and 1994 and followed until 2011.

Results

Over two decades, the incidence of CFRD among 11- to 16-year-old children remained unchanged at 12–14%, while the proportion of children with chronic pulmonary infection at age 10 declined from 31 to 8% (p < 0.001). Severe CF-mutation, i.e., group I and II mutations, were associated with diabetes (p = 0.003). Female gender was borderline associated with diabetes among adolescents (p = 0.06). No significant worsening in pulmonary function, BMI or survival was identified when comparing CFRD patients to CF patients without CFRD.

Conclusions

The incidence of diabetes among adolescence with CF has not changed over the last two decades. Severe CF mutations are a risk factor for CFRD, and female gender is borderline associated with CFRD among adolescents. Pulmonary function, BMI and survival were comparable regardless of the onset of CFRD.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.